S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:TGTX

TG Therapeutics News Headlines

$15.69
+0.28 (+1.82%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$15.03
$15.85
50-Day Range
$15.20
$34.80
52-Week Range
$12.62
$56.50
Volume
1.53 million shs
Average Volume
1.81 million shs
Market Capitalization
$2.22 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.93
Get TG Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

TG Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TGTX
News Sentiment

0.57

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TGTX Articles
This Week

0

2

TGTX Articles
Average Week



TG Therapeutics (NASDAQ:TGTX) News Headlines Today

SourceHeadline
MarketBeat logoInsider Selling: TG Therapeutics, Inc. (NASDAQ:TGTX) CFO Sells 75,312 Shares of Stock
americanbankingnews.com - January 7 at 7:10 PM
insidertrades.com logoTG Therapeutics, Inc. (NASDAQ:TGTX) CEO Sells $720,940.80 in Stock
insidertrades.com - January 7 at 7:10 PM
finance.yahoo.com logoTG Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 11:56 AM
nasdaq.com logoDespite Lacking Profits TG Therapeutics (NASDAQ:TGTX) Seems To Be On Top Of Its Debt
nasdaq.com - January 4 at 5:49 PM
finance.yahoo.com logoTG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million
finance.yahoo.com - January 4 at 7:48 AM
MarketBeat logo$11.56 Million in Sales Expected for TG Therapeutics, Inc. (NASDAQ:TGTX) This Quarter
americanbankingnews.com - January 4 at 1:45 AM
MarketBeat logoTG Therapeutics (NASDAQ:TGTX) Shares Gap Down to $19.39
americanbankingnews.com - December 28 at 11:22 AM
MarketBeat logoTG Therapeutics (NASDAQ:TGTX) Stock Price Down 4.2%
americanbankingnews.com - December 27 at 11:20 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
finance.yahoo.com - December 14 at 8:40 PM
finance.yahoo.com logoTG Therapeutics Announces Data Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 13 at 8:34 AM
finance.yahoo.com logoDo Hedge Funds Love TG Therapeutics Inc (TGTX)?
finance.yahoo.com - December 13 at 12:50 AM
finance.yahoo.com logoTG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 63rd American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 10 at 9:48 AM
benzinga.com logoTG THERAPEUTICS ALERT: Bragar Eagel & Squire...
benzinga.com - December 5 at 3:03 AM
benzinga.com logoTG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm
benzinga.com - December 2 at 10:28 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Investigation of TG Therapeutics, Inc. Announced by Holzer & Holzer, LLC
finance.yahoo.com - December 1 at 6:26 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Labaton Sucharow Investigating TG Therapeutics, Inc. - TGTX
finance.yahoo.com - December 1 at 6:26 PM
finance.yahoo.com logoBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of TG Therapeutics, Inc. (TGTX) Investigation
finance.yahoo.com - December 1 at 1:26 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
finance.yahoo.com - November 30 at 5:59 PM
finance.yahoo.com logoWhy TG Therapeutics Is Plunging More Than 40% Today
finance.yahoo.com - November 30 at 12:59 PM
benzinga.com logoWhy TG Therapeutics Stock Is Falling Today
benzinga.com - November 30 at 11:11 AM
finance.yahoo.com logoTG Therapeutics Provides Regulatory Update
finance.yahoo.com - November 30 at 7:59 AM
finance.yahoo.com logoWhy TG Therapeutics Is Crashing Today
finance.yahoo.com - November 23 at 8:59 AM
nasdaq.com logoTG Therapeutics Enters Oversold Territory (TGTX)
nasdaq.com - November 15 at 2:36 PM
finance.yahoo.com logoTG Therapeutics to Participate in the Jefferies London Healthcare Conference
finance.yahoo.com - November 15 at 9:36 AM
finance.yahoo.com logoTG Therapeutics to Participate in the B. Riley Securities Fall 2021 Growth Biotech Best Ideas Virtual Series
finance.yahoo.com - November 9 at 9:42 AM
nasdaq.com logoWhat Type Of Shareholders Own The Most Number of TG Therapeutics, Inc. (NASDAQ:TGTX) Shares?
nasdaq.com - November 4 at 8:29 PM
finance.yahoo.com logoTG Therapeutics, inc (TGTX) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 4 at 3:28 PM
sg.finance.yahoo.com logoTG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
sg.finance.yahoo.com - November 4 at 10:27 AM
nasdaq.com logoTG Therapeutics (TGTX) Reports Q3 Loss, Misses Revenue Estimates
nasdaq.com - November 4 at 10:27 AM
finance.yahoo.com logoHow Much Of TG Therapeutics, Inc. (NASDAQ:TGTX) Do Insiders Own?
finance.yahoo.com - November 3 at 8:00 PM
finance.yahoo.com logoTG Therapeutics to Host Conference Call on Third Quarter 2021 Financial Results and Business Update
finance.yahoo.com - November 1 at 8:22 AM
nasdaq.com logoInteresting TGTX Put And Call Options For December 17th
nasdaq.com - October 18 at 12:38 PM
finance.yahoo.com logoTG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
finance.yahoo.com - October 14 at 3:48 PM
finance.yahoo.com logoTG Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis
finance.yahoo.com - September 30 at 12:00 PM
finance.yahoo.com logoTG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
finance.yahoo.com - September 29 at 3:59 PM
finance.yahoo.com logoTG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 23 at 9:05 AM
finance.yahoo.com logoTG Therapeutics Announces Publication of Results from an Integrated Safety Analysis of UKONIQ® (umbralisib) in Blood Advances
finance.yahoo.com - September 23 at 9:05 AM
nasdaq.com logoThe five-year returns have been incredible for TG Therapeutics (NASDAQ:TGTX) shareholders despite underlying losses increasing
nasdaq.com - September 20 at 6:32 PM
finance.yahoo.com logoTG Therapeutics Announces Combination Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
finance.yahoo.com - September 20 at 8:22 AM
finance.yahoo.com logoTG Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 9 at 6:12 PM
finance.yahoo.com logoThe five-year returns have been fantastic for TG Therapeutics (NASDAQ:TGTX) shareholders despite underlying losses increasing
finance.yahoo.com - September 3 at 4:45 PM
finance.yahoo.com logoTG Therapeutics Announces Data Presentations at the Upcoming XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
finance.yahoo.com - August 30 at 7:53 AM
msn.com logoUnderstanding TG Therapeutics's Unusual Options Activity
msn.com - August 16 at 4:18 PM
finance.yahoo.com logoDo Options Traders Know Something About TG Therapeutics (TGTX) Stock We Don't?
finance.yahoo.com - August 16 at 4:18 PM
finance.yahoo.com logoTG Therapeutics: Time to Bottom Fish?
finance.yahoo.com - August 4 at 1:07 PM
finance.yahoo.com logoTG Therapeutics, inc (TGTX) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 4 at 8:07 AM
msn.com logoWhy TG Therapeutics Shares Are Trading Lower Today
msn.com - August 2 at 5:49 PM
finance.yahoo.com logoHere's Why TG Therapeutics Stock Is Getting Hammered Today
finance.yahoo.com - August 2 at 5:49 PM
nasdaq.com logoTG Therapeutics Becomes Oversold (TGTX)
nasdaq.com - August 2 at 12:49 PM
finance.yahoo.com logoTG Therapeutics (TGTX) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 2 at 12:49 PM
Get TG Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.